BioMimetic Therapeutics, Inc. Patent Portfolio Further Strengthened
Feb. 1, 2010
|
|
|
BioMimetic Therapeutics Strengthens its Agreement with Novartis for Exclusive Supply of rhPDGF-BB
Jan. 6, 2010
|
|
|
BioMimetic Therapeutics Ships Augment™ Bone Graft to Canadian Distributor; Product Now Available for Sale to Canadian Customers
Dec. 11, 2009
|
|
|
Novo A/S Implements 10b5-1 Trading Plan for Purchase of Additional BioMimetic Therapeutics Shares
Dec. 8, 2009
|
|
|
BioMimetic Therapeutics Reports 2009 Third Quarter Earnings Results; Company's Second Orthopedic Product Candidate Enters Pivotal Trial for Foot and Ankle Fusion Indications
Nov. 5, 2009
|
|
|
BioMimetic Therapeutics Receives First Orthopedic Marketing Approval for Augment Bone Graft
Nov. 3, 2009
|
|
|
BioMimetic Therapeutics to Report 2009 Third Quarter Financial Results on November 5
Nov. 3, 2009
|
|
|
BioMimetic Announces Positive Top-Line Data from its Augment Bone Graft North American Pivotal Trial; Augment Demonstrates Non-Inferiority to Autograft
Oct. 13, 2009
|
|
|
BioMimetic Therapeutics Reports 2009 Second Quarter Earnings Results
Aug. 10, 2009
|
|
|
BioMimetic Therapeutics to Present at Canaccord Adams Global Growth Conference
Aug. 7, 2009
|
|
|
BioMimetic Therapeutics, Inc. Announces Preliminary Results of Rights Offering
June 23, 2009
|
|
|
BioMimetic Therapeutics, Inc. Announces Extension of Rights Offering
June 11, 2009
|
|
|
BioMimetic Therapeutics Releases 2009 First Quarter Financial Results
May 7, 2009
|
|
|
BioMimetic Therapeutics to Report 2009 First Quarter Financial Results on May 7
May 5, 2009
|
|
|
BioMimetic Therapeutics, Inc. Announces an $8 Million Private Placement; Company Intends to Commence Rights Offering
April 6, 2009
|
|
|
BioMimetic Therapeutics, Inc. Announces Record Date for Rights Offering
April 16, 2009
|
|
|
BioMimetic Therapeutics President and CEO Adopts 10b5-1 Trading Plan
March 20, 2009
|
|
|
BioMimetic Therapeutics Reports 2008 Fourth Quarter and Year End Results
March 12, 2009
|
|
|
BioMimetic Therapeutics to Report 2008 Fourth Quarter and Year End Financial Results on March 12; Company to Host Conference Call March 13
March 11, 2009
|
|
|
BioMimetic Therapeutics, Inc. to Highlight Pre-Clinical and Clinical Activities at ORS and AAOS Meetings; Company to host an analyst and investor meeting February 26
Feb. 19, 2009
|
|
|
BioMimetic Therapeutics, Inc. Closes Enrollment with 436 Patients in North American Pivotal Study for Augment™ Bone Graft; Company Will File Modular PMA with the FDA Beginning This Spring
Jan. 7, 2009
|
|
|
